Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  adenosine-A2A receptor antagonist CPI-444
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CPI-444-001, NCI-2016-00227, NCT02655822
Start Over